메뉴 건너뛰기




Volumn 75, Issue 6, 2009, Pages 580-582

Prevention of vascular calcification with bisphosphonates without affecting bone mineralization: A new challenge?

Author keywords

[No Author keywords available]

Indexed keywords

ETIDRONIC ACID; HYDROXYAPATITE; PAMIDRONIC ACID; RISEDRONIC ACID; ZOLEDRONIC ACID;

EID: 61349134149     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2008.663     Document Type: Note
Times cited : (16)

References (12)
  • 1
    • 0032828179 scopus 로고    scopus 로고
    • Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure
    • Rix M, Andreassen H, Eskildsen P et al. Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure. Kidney Int 1999; 56: 1084-1093.
    • (1999) Kidney Int , vol.56 , pp. 1084-1093
    • Rix, M.1    Andreassen, H.2    Eskildsen, P.3
  • 2
    • 0037058829 scopus 로고    scopus 로고
    • Acetylated low-density lipoprotein stimulates human vascular smooth muscle cell calcification by promoting osteoblastic differentiation and inhibiting phagocytosis
    • Proudfoot D, Davies JD, Skepper JN et al. Acetylated low-density lipoprotein stimulates human vascular smooth muscle cell calcification by promoting osteoblastic differentiation and inhibiting phagocytosis. Circulation 2002; 106: 3044-3050.
    • (2002) Circulation , vol.106 , pp. 3044-3050
    • Proudfoot, D.1    Davies, J.D.2    Skepper, J.N.3
  • 3
    • 0035158822 scopus 로고    scopus 로고
    • Atherogenic high-fat diet reduces bone mineralization in mice
    • Parhami F, Tintut Y, Beamer WG et al. Atherogenic high-fat diet reduces bone mineralization in mice. J Bone Miner Res 2001; 16: 182-188.
    • (2001) J Bone Miner Res , vol.16 , pp. 182-188
    • Parhami, F.1    Tintut, Y.2    Beamer, W.G.3
  • 4
    • 0032079445 scopus 로고    scopus 로고
    • Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification
    • Bucay N, Sarosi I, Dunstan CR et al. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev 1998; 12: 1260-1268.
    • (1998) Genes Dev , vol.12 , pp. 1260-1268
    • Bucay, N.1    Sarosi, I.2    Dunstan, C.R.3
  • 5
    • 0037144676 scopus 로고    scopus 로고
    • SB 242784, a selective inhibitor of the osteoclastic V-H+ATPase, inhibits arterial calcification in the rat
    • Price PA, June HH, Buckley JR et al. SB 242784, a selective inhibitor of the osteoclastic V-H+ATPase, inhibits arterial calcification in the rat. Circ Res 2002; 91: 547-552.
    • (2002) Circ Res , vol.91 , pp. 547-552
    • Price, P.A.1    June, H.H.2    Buckley, J.R.3
  • 6
    • 0035723970 scopus 로고    scopus 로고
    • Osteoprotegerin inhibits artery calcification induced by warfarin and by vitamin D
    • Price PA, June HH, Buckley JR et al. Osteoprotegerin inhibits artery calcification induced by warfarin and by vitamin D. Arterioscler Thromb Vasc Biol 2001; 21: 1610-1616.
    • (2001) Arterioscler Thromb Vasc Biol , vol.21 , pp. 1610-1616
    • Price, P.A.1    June, H.H.2    Buckley, J.R.3
  • 7
    • 0035036363 scopus 로고    scopus 로고
    • Bisphosphonates alendronate and ibandronate inhibit artery calcification at doses comparable to those that inhibit bone resorption
    • Price PA, Faus SA, Williamson MK. Bisphosphonates alendronate and ibandronate inhibit artery calcification at doses comparable to those that inhibit bone resorption. Arterioscler Thromb Vasc Biol 2001; 21: 817-824.
    • (2001) Arterioscler Thromb Vasc Biol , vol.21 , pp. 817-824
    • Price, P.A.1    Faus, S.A.2    Williamson, M.K.3
  • 8
    • 33750220360 scopus 로고    scopus 로고
    • Artery calcification in uremic rats is increased by a low protein diet and prevented by treatment with ibandronate
    • Price PA, Roublick AM, Williamson MK. Artery calcification in uremic rats is increased by a low protein diet and prevented by treatment with ibandronate. Kidney Int 2006; 70: 1577-1583.
    • (2006) Kidney Int , vol.70 , pp. 1577-1583
    • Price, P.A.1    Roublick, A.M.2    Williamson, M.K.3
  • 9
    • 61349180704 scopus 로고    scopus 로고
    • Effect of bisphosphonates on vascular calcification and bone metabolism in experimental renal failure
    • Lomashvili KA, Moni er-Faugere M-C, Wang X et al. Effect of bisphosphonates on vascular calcification and bone metabolism in experimental renal failure. Kidney Int 2009; 75: 617-625.
    • (2009) Kidney Int , vol.75 , pp. 617-625
    • Lomashvili, K.A.1    Moni er-Faugere, M.-C.2    Wang, X.3
  • 10
    • 33847275569 scopus 로고    scopus 로고
    • Prevention of aortic calcification by etidronate in the renal failure rat model
    • Tamura K, Suzuki Y, Matsushita M et al. Prevention of aortic calcification by etidronate in the renal failure rat model. Eur J Pharmacol 2007; 558: 159-166.
    • (2007) Eur J Pharmacol , vol.558 , pp. 159-166
    • Tamura, K.1    Suzuki, Y.2    Matsushita, M.3
  • 11
    • 3142654694 scopus 로고    scopus 로고
    • Inhibitory effects of etidronate on the progression of vascular calcification in hemodialysis patients
    • Hashiba H, Aizawa S, Tamura K et al. Inhibitory effects of etidronate on the progression of vascular calcification in hemodialysis patients. Ther Apher Dial 2004; 8: 241-247.
    • (2004) Ther Apher Dial , vol.8 , pp. 241-247
    • Hashiba, H.1    Aizawa, S.2    Tamura, K.3
  • 12
    • 4544291461 scopus 로고    scopus 로고
    • Effects of cyclic intermittent etidronate therapy on coronary artery calcification in patients receiving long-term hemodialysis
    • Nitta K, Akiba T, Suzuki K et al. Effects of cyclic intermittent etidronate therapy on coronary artery calcification in patients receiving long-term hemodialysis. Am J Kidney Dis 2004; 44: 680-688
    • (2004) Am J Kidney Dis , vol.44 , pp. 680-688
    • Nitta, K.1    Akiba, T.2    Suzuki, K.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.